Patient randomization and clinical supplies management services provider Cenduit is expanding its headquarters in Durham, North Carolina,US, and its office in Basel, Switzerland.
The expansion will add more room space to the company's headquarters and triples the size of its office in Basel.
Cenduit CEO Jogin Desai said the firm's decision to increase offices and infrastructure is required to support its global investment in capacity.
"Our aim is to provide the best possible support to sites and sponsors and to do this through continued investment in our customer-facing groups," Desai added.
Cenduit said it has also appointed Chris Dailey as global head of technology.
Dailey in his new role will lead technology and service initiatives, which aim to provide additional system functionality as well as improving the user experience for those interfacing with Cenduit Interactive Response Technology (IRT) to conduct clinical trials at sites across the globe.
